Alejandro L Arregger
Overview
Explore the profile of Alejandro L Arregger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
93
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arregger A, Cardoso E, Zucchini A, Aguirre E, Elbert A, Contreras L
Steroids
. 2014 Apr;
84:57-63.
PMID: 24686207
Background: Sustained hypotension among patients with end stage renal disease on dialysis (ESRDh) varies from 5.0% to 12.0%. Despite their role in the regulation of blood pressure (BP) corticoadrenal hormones...
2.
Cardoso E, Arregger A, Monardes G, Contreras L
Steroids
. 2013 Mar;
78(5):476-82.
PMID: 23485687
Background: The prevalence of Cushing's syndrome (CS) in at-risk populations in developing countries remains uncertain. Evening urinary cortisol (UFC(22-23)) and salivary cortisol after treatment with 1-mg DST (SAFdex) have seldom...
3.
Arregger A, Cardoso E, Sandoval O, Monardes Tumilasci E, Sanchez R, Contreras L
Am J Ther
. 2012 Jul;
21(4):e110-6.
PMID: 22820717
Clinical management of persistent adrenocorticotropin hormone (ACTH) excess in Nelson syndrome (NS) and Cushing disease (CD) remains a challenge. Somatostatin and its analogs as octreotide decrease ACTH secretion through somatostatin...
4.
Cardoso E, Contreras L, Tumilasci E, Elbert A, Aguirre E, Aquilano D, et al.
Nephrol Dial Transplant
. 2010 Jul;
26(2):677-83.
PMID: 20659904
Background: Hypogonadism is frequent in patients with end-stage renal disease (ESRD). Salivary testosterone (Sal-T) is a non-invasive tool to screen androgen deficiency in adult male with normal renal function. However,...
5.
Cardoso E, Arregger A, Tumilasci O, Elbert A, Contreras L
Scand J Clin Lab Invest
. 2008 Nov;
69(3):330-4.
PMID: 19031172
Objective: Experimental studies describe how urea is excreted through salivary glands and correlates with serum levels independently of salivary flow rate. This study confirms that salivary urea (SaU) is a...
6.
Cardoso E, Arregger A, Tumilasci O, Contreras L
Clin Endocrinol (Oxf)
. 2008 Aug;
70(4):516-21.
PMID: 18710466
Objective: The diagnosis of Cushing's syndrome (CS) remains a challenge in clinical endocrinology. The aim of this study was to determine the reproducibility and diagnostic value of late-night salivary cortisol...
7.
Ostuni M, Tumilasci O, Peranzi G, Cardoso E, Contreras L, Arregger A, et al.
Biol Cell
. 2008 Feb;
100(7):427-39.
PMID: 18269350
Background Information: TSPO (translocator protein), previously known as PBR (peripheral-type benzodiazepine receptor), is a ubiquitous 18 kDa transmembrane protein that participates in diverse cell functions. High-affinity TSPO ligands are best...
8.
Arregger A, Contreras L, Tumilasci O, Aquilano D, Cardoso E
Clin Endocrinol (Oxf)
. 2007 Oct;
67(5):656-62.
PMID: 17953627
Objective: This study was to demonstrate that Sal-T is a reliable biomarker of androgen status in the diagnosis of male hypogonadism. Design: In order to validate the salivary testosterone assay...
9.
Arregger A, Cardoso E, Tumilasci O, Contreras L
Steroids
. 2007 Oct;
73(1):77-82.
PMID: 17945323
Objectives: Salivary cortisol has been proposed a surrogate marker for free serum cortisol measurements. The aim of this study was to ascertain the diagnostic value of basal and stimulated salivary...
10.
Tumilasci O, Cardoso E, Contreras L, Belforte J, Arregger A, Ostuni M
Acta Odontol Latinoam
. 2007 Jul;
19(2):47-51.
PMID: 17645210
The present study describes a methodology to assess the salivary flow rate in humans. Whole saliva was obtained from the floor of the mouth with a plastic dental ejector and...